Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |